Athersys Inc

ATHX

NASDAQ. Currency in USD

1.85 +0.22 ( +13.50% )

Real time prices: September 30

Market Cap.
564.45M
Beta (5Y monthly)
-1.04
Price/Earnings
-
EPS (TTM)
-8.50
Forward Dividend
0.00 (0.00%)
Ex-Dividend Date
Volume
1.24M
1y Target Est.
3.75
Day's Range
1.57
-
1.90
52 Week's Range
1.13
-
35.50

Historical Summary

Performance
EPS growth
Share Buybacks

About Athersys Inc

Sector
Healthcare
Industry
Biotechnology
Website
https://www.athersys.com
Exchange
NASDAQ (XNAS)
Shares Outstanding
235.24M
Employees
104
Address
3201 Carnegie Avenue, Cleveland, OH, United States, 44115-2634
Athersys, Inc., a biotechnology company, focuses on the research and development activities in the field of regenerative medicine. Its clinical development programs are focused on treating neurological conditions, cardiovascular diseases, inflammatory and immune disorders, and pulmonary and other conditions. The company's lead platform product includes MultiStem cell therapy, an allogeneic stem cell product, which is in Phase III clinical study for the treatment of patients suffering from neurological damage from an ischemic stroke, as well as for acute respiratory distress syndrome, trauma complications, HSC transplant support, and other indications. It also develops MultiStem cell therapy to promote tissue repair and healing for animal patients, including those suffering from serious conditions with unmet medical needs. The company has license and collaboration agreements with Healios K.K. to develop and commercialize MultiStem cell therapy for ischemic stroke, acute respiratory distress syndrome, and ophthalmological indications, as well as for the treatment of liver, kidney, pancreas, and intestinal tissue diseases; and the University of Minnesota to develop MultiStem cell therapy platform. Athersys, Inc. was founded in 1995 and is headquartered in Cleveland, Ohio.

Latest news

Why Aridis Pharmaceuticals Shares Plunged Around 30%; Here Are 81 Biggest Movers From Yesterday
Why Aridis Pharmaceuticals Shares Plunged Around 30%; Here Are 81 Biggest Movers From Yesterday

Gainers LAVA Therapeutics N.V. (NASDAQ: LVTX) shares climbed 97.5% to close at $4.74 on Monday...
By Benzinga - 5 days ago

Athersys, Golden Sun Education Group And Some Other Big Stocks Moving Lower On Monday
Athersys, Golden Sun Education Group And Some Other Big Stocks Moving Lower On Monday

U.S. stocks traded mixed, with the Dow Jones dropping around 80 points on Monday. Here...
By Benzinga - 6 days ago

Hot Penny Stocks to Buy This Week? 3 to Watch Now
Hot Penny Stocks to Buy This Week? 3 to Watch Now

Which penny stocks are you watching today? The post Hot Penny Stocks to Buy This...
By PennyStocks - 6 days ago

Why NanoVibronix Shares Surged Over 25%; Here Are 82 Biggest Movers From Friday
Why NanoVibronix Shares Surged Over 25%; Here Are 82 Biggest Movers From Friday

Gainers Golden Sun Education Group Limited (NASDAQ: GSUN) shares surged 92.1% to settle at $52.89...
By Benzinga - 1 week ago

Best Penny Stocks To Buy: 3 High Volume Stocks To Watch Today
Best Penny Stocks To Buy: 3 High Volume Stocks To Watch Today

High volume penny stocks to watch before next week. The post Best Penny Stocks To...
By PennyStocks - 1 week ago

Dow Hits New 2022 Low; Gold Falls Sharply
Dow Hits New 2022 Low; Gold Falls Sharply

U.S. stocks extended losses toward the end of trading, with the Dow Jones dropping to...
By Benzinga - 1 week ago

Why Shares Of Oil & Gas Companies Are Trading Lower, Here Are 62 Stocks Moving In Friday's Mid-Day Session
Why Shares Of Oil & Gas Companies Are Trading Lower, Here Are 62 Stocks Moving In Friday's Mid-Day Session

Gainers Kiromic BioPharma, Inc. (NASDAQ: KRBP) shares jumped 87% to $0.4791. Kiromic BioPharma, said on...
By Benzinga - 1 week ago